🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 23 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 26/04/2004 | 44,66 | 44,83 | 44,48 | 44,50 | -0,26% | 0,77% | 3.817.026 |
| 23/04/2004 | 44,99 | 44,99 | 44,27 | 44,62 | +0,04% | 1,61% | 4.012.687 |
| 22/04/2004 | 44,13 | 44,99 | 43,69 | 44,60 | +0,52% | 2,94% | 7.468.886 |
| 21/04/2004 | 43,99 | 45,08 | 43,94 | 44,37 | +0,63% | 2,58% | 6.093.806 |
| 20/04/2004 | 44,79 | 44,79 | 44,08 | 44,09 | -1,56% | 1,58% | 4.708.035 |
| 19/04/2004 | 44,75 | 44,90 | 44,38 | 44,79 | -0,30% | 1,17% | 5.784.122 |
| 16/04/2004 | 45,09 | 45,21 | 44,58 | 44,92 | +0,21% | 1,40% | 8.015.418 |
| 15/04/2004 | 43,56 | 44,99 | 43,56 | 44,83 | +3,39% | 3,29% | 13.231.838 |
| 14/04/2004 | 42,37 | 43,42 | 42,27 | 43,36 | +1,93% | 2,70% | 9.200.916 |
| 13/04/2004 | 42,87 | 43,03 | 42,35 | 42,54 | -0,69% | 1,60% | 6.373.517 |
| 12/04/2004 | 42,59 | 42,94 | 42,37 | 42,83 | +0,58% | 1,34% | 5.454.106 |
| 08/04/2004 | 43,02 | 43,13 | 42,25 | 42,59 | -0,47% | 2,04% | 6.343.125 |
| 07/04/2004 | 43,08 | 43,18 | 42,71 | 42,79 | -0,69% | 1,09% | 5.138.239 |
| 06/04/2004 | 42,94 | 43,08 | 42,86 | 43,08 | -0,31% | 0,51% | 5.487.014 |
| 05/04/2004 | 43,32 | 43,34 | 42,35 | 43,22 | +0,51% | 2,29% | 4.897.618 |
| 02/04/2004 | 43,51 | 43,65 | 42,55 | 43,00 | +0,60% | 2,54% | 7.634.261 |
| 01/04/2004 | 42,51 | 43,18 | 42,41 | 42,74 | +1,36% | 1,80% | 6.060.479 |
| 31/03/2004 | 42,18 | 42,45 | 41,94 | 42,17 | +0,20% | 1,22% | 10.088.153 |
| 30/03/2004 | 42,44 | 42,51 | 41,79 | 42,08 | -1,05% | 1,69% | 7.722.817 |
| 29/03/2004 | 42,27 | 42,62 | 41,94 | 42,53 | +1,30% | 1,63% | 5.698.081 |
| 26/03/2004 | 41,75 | 42,42 | 41,68 | 41,98 | +0,71% | 1,78% | 5.871.734 |
| 25/03/2004 | 41,36 | 41,97 | 41,13 | 41,69 | +1,58% | 2,03% | 8.132.794 |
| 24/03/2004 | 41,89 | 42,10 | 40,89 | 41,04 | -2,14% | 2,89% | 8.837.050 |
| 23/03/2004 | 41,70 | 42,15 | 41,67 | 41,94 | +0,85% | 1,14% | 6.212.125 |
| 22/03/2004 | 41,72 | 42,13 | 41,39 | 41,58 | -0,43% | 1,76% | 10.136.046 |
| 19/03/2004 | 42,54 | 42,73 | 41,76 | 41,77 | -1,79% | 2,29% | 8.308.858 |
| 18/03/2004 | 42,32 | 42,70 | 42,05 | 42,53 | +0,41% | 1,53% | 7.997.707 |
| 17/03/2004 | 43,23 | 43,30 | 42,08 | 42,36 | -1,60% | 2,83% | 11.958.518 |
| 16/03/2004 | 43,15 | 43,16 | 42,81 | 43,04 | +0,58% | 0,82% | 6.689.803 |
| 15/03/2004 | 43,27 | 43,32 | 42,74 | 42,80 | -0,66% | 1,35% | 7.222.711 |